leukotriene A4 hydrolase inhibitors (Cardoz)

N/A

Report date: 2025/03/20 20:00:06
NME

Base Information

Drug Nameleukotriene A4 hydrolase inhibitors (Cardoz)
Drug Alias NameN/A
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionLeukotriene A-4 hydrolase inhibitors
TargetsLeukotriene A-4 hydrolase
Therapy Area/IndicationsCardiovascular Diseases
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritorySweden
CombinationsNo
Global Highest StatusPending (Preclinical)
Highest Status in ChinaN/A
Originator CompaniesRspr Pharma Ab
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesRspr Pharma Ab
Active IndicationsN/A
Inactive IndicationsCardiovascular Diseases

Other Information

ATC CodeN/A
Related LinksN/A